What Next: TBD

What’s Taking the FDA So Long?

Full approval of the vaccines could move the needle on U.S. vaccination rates. So what’s the holdup?


Episode Notes

Experts say that a “fully approved” designation for the vaccines could have sweeping effects. Broader vaccination mandates, inclusion for new age groups, and reassurance for those hesitant to take a vaccine without the designation. As calls for approval grow louder and more urgent, the Food and Drug Administration is yet to give its blessing. What’s happening inside the FDA as they work toward this milestone?

Guest: Sarah Owermohle, health care reporter at Politico


About the Show

Every Friday and Sunday, Slate’s popular daily news podcast What Next brings you TBD, a clear-eyed look into the future. From fake news to fake meat, algorithms to augmented reality, Lizzie O’Leary is your guide to the tech industry and the world it’s creating for us to live in.

All episodes


  • Lizzie O’Leary is the host of What Next: TBD, Slate’s show about technology, power, and the future. Previously, she created and hosted Marketplace Weekend. She has reported for CNN, Bloomberg News, and the New York Times Magazine, among others. She is also a contributing writer at the Atlantic.